Combined effects of sodium-glucose cotransporter 2 inhibitor and angiotensin receptor-neprilysin inhibitor on renal function in cardiovascular disease patients with type 2 diabetes mellitus: a retrospective cohort study.
鈉葡萄糖共同轉運蛋白2抑制劑和血管收縮素受體-內脢酶抑制劑對2型糖尿病心血管疾病患者腎功能的聯合影響:一項回顧性cohort研究。
Front Endocrinol (Lausanne) 2024-03-06
Long-Term Impact of Renin-Angiotensin System Inhibitors for Secondary Prevention in Patients with Chronic Kidney Disease Who Underwent Percutaneous Coronary Intervention.
慢性腎臟病患者接受經皮冠狀動脈介入治療後,腎素-血管緊張素系統抑制劑對二次預防的長期影響。
Kidney Dis (Basel) 2024-02-10
Angiotensin Receptor Blocker-Neprilysin Inhibitor for Heart Failure with Reduced Ejection Fraction.
心衰竭伴隨降低射血分數的血管緊張素受體阻斷劑-內脢肽酶抑製劑。
Pharmacol Res 2024-05-13
Consensus Statement from India on the Renal Benefits of ARNi, SGLT-2i, and Bisoprolol in Chronic Kidney Disease.
印度有關 ARNi、SGLT-2i 和 Bisoprolol 對慢性腎臟病的腎臟益處共識聲明。
J Assoc Physicians India 2024-06-17
An Updated Review of the Management of Chronic Heart Failure in Patients with Chronic Kidney Disease.
慢性腎病患者慢性心衰竭管理的最新回顧。
Rev Cardiovasc Med 2024-07-30
The impact of angiotensin-receptor neprilysin inhibitors on cardiovascular events and solute transport function in peritoneal dialysis patients: a multicenter retrospective controlled study.
血管緊張素受體中性肽酶抑制劑對腹膜透析患者心血管事件及溶質運輸功能的影響:一項多中心回顧性對照研究。
Ren Fail 2024-11-29
Impact of Renin-Angiotensin-Aldosterone System Inhibition on Advanced Chronic Kidney Disease Progression - a Retrospective Observational Study.
腎素-血管緊張素-醛固酮系統抑制對於晚期慢性腎病進展的影響 - 一項回顧性觀察研究。
Am J Nephrol 2025-02-26